22.07.2011 • News

Syngenta H1 Profit Up

Syngenta reported a 14% rise in its first-half net income attributable to the company's shareholders to $1.43 billion from $1.25 billion last year. Excluding restructuring and impairment, quarterly earnings per share were $15.60, higher than $13.95 in the year earlier period.

The company reported first-half sales of $7.7 billion, up 14% from $6.74 billion in the comparable period a year ago. Sales at constant exchange rates or CER increased by 12%.

Mike Mack, chief executive, noted, "We expect to generate 2011 full year free cash flow in excess of $1 billion.

In addition, the outlook for pricing for the rest of the year is positive and we expect stable pricing for the full year. For the 2012 season, we are currently raising prices across the business with the aim of achieving an overall increase in the mid single digits."

 

Company

Syngenta International AG


Basel
Switzerland

Company contact







Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

From Catalogue to Collaboration

Enamine's Expert Insights Collection Is Free to Download
Enamine’s 35 Years of Advancing Drug Discovery

Enamine's Expert Insights Collection Is Free to Download

From catalogue to collaboration — explore 35 years of drug discovery breakthroughs, novel building blocks, and the science shaping tomorrow's medicines. Download your complimentary copy now.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.